Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Oxford Nanopore management to meet with Piper Sandler » 05:55
10/06/22
10/06
05:55
10/06/22
05:55
ONTTF

Oxford Nanopore

$3.08 /

-0.061 (-1.94%)

Meetings to be held in…

Meetings to be held in Boston October 4-5 and in New York on October 6 hosted by Piper Sandler.

ShowHide Related Items >><<
ONTTF Oxford Nanopore
$3.08 /

-0.061 (-1.94%)

09/25/22 Piper Sandler
Oxford Nanopore price target lowered to 650 GBp from 750 GBp at Piper Sandler
09/14/22 JPMorgan
Oxford Nanopore price target raised to 720 GBp from 710 GBp at JPMorgan
08/23/22 Barclays
Oxford Nanopore price target lowered to 420 GBp from 500 GBp at Barclays
05/31/22 Barclays
Oxford Nanopore price target lowered to 500 GBp from 700 GBp at Barclays
Conference/Events
Oxford Nanopore management to meet with Piper Sandler » 04:55
10/05/22
10/05
04:55
10/05/22
04:55
ONTTF

Oxford Nanopore

$3.15 /

+0.135 (+4.49%)

Meetings to be held in…

Meetings to be held in Boston October 4-5 and in New York on October 6 hosted by Piper Sandler.

ShowHide Related Items >><<
ONTTF Oxford Nanopore
$3.15 /

+0.135 (+4.49%)

09/25/22 Piper Sandler
Oxford Nanopore price target lowered to 650 GBp from 750 GBp at Piper Sandler
09/14/22 JPMorgan
Oxford Nanopore price target raised to 720 GBp from 710 GBp at JPMorgan
08/23/22 Barclays
Oxford Nanopore price target lowered to 420 GBp from 500 GBp at Barclays
05/31/22 Barclays
Oxford Nanopore price target lowered to 500 GBp from 700 GBp at Barclays
Conference/Events
Oxford Nanopore management to meet with Piper Sandler » 08:29
10/04/22
10/04
08:29
10/04/22
08:29
ONTTF

Oxford Nanopore

$3.01 /

+0.135 (+4.70%)

Meetings to be held in…

Meetings to be held in Boston October 4-5 and in New York on October 6 hosted by Piper Sandler.

ShowHide Related Items >><<
ONTTF Oxford Nanopore
$3.01 /

+0.135 (+4.70%)

ONTTF Oxford Nanopore
$3.01 /

+0.135 (+4.70%)

09/25/22 Piper Sandler
Oxford Nanopore price target lowered to 650 GBp from 750 GBp at Piper Sandler
09/14/22 JPMorgan
Oxford Nanopore price target raised to 720 GBp from 710 GBp at JPMorgan
08/23/22 Barclays
Oxford Nanopore price target lowered to 420 GBp from 500 GBp at Barclays
05/31/22 Barclays
Oxford Nanopore price target lowered to 500 GBp from 700 GBp at Barclays
Recommendations
Oxford Nanopore price target lowered to 650 GBp from 750 GBp at Piper Sandler » 19:04
09/25/22
09/25
19:04
09/25/22
19:04
ONTTF

Oxford Nanopore

$2.76 /

-0.31 (-10.11%)

Piper Sandler analyst…

Piper Sandler analyst David Westenberg lowered the firm's price target on Oxford Nanopore to 650 GBp from 750 GBp following the company's earnings report. The analyst keeps an Overweight rating on the shares.

ShowHide Related Items >><<
ONTTF Oxford Nanopore
$2.76 /

-0.31 (-10.11%)

ONTTF Oxford Nanopore
$2.76 /

-0.31 (-10.11%)

09/14/22 JPMorgan
Oxford Nanopore price target raised to 720 GBp from 710 GBp at JPMorgan
08/23/22 Barclays
Oxford Nanopore price target lowered to 420 GBp from 500 GBp at Barclays
05/31/22 Barclays
Oxford Nanopore price target lowered to 500 GBp from 700 GBp at Barclays
04/29/22 RBC Capital
Oxford Nanopore price target lowered to 400 GBp from 700 GBp at RBC Capital
Recommendations
Oxford Nanopore price target raised to 720 GBp from 710 GBp at JPMorgan » 15:03
09/14/22
09/14
15:03
09/14/22
15:03
ONTTF

Oxford Nanopore

$3.35 /

+0.03 (+0.90%)

JPMorgan analyst James…

JPMorgan analyst James Gordon raised the firm's price target on Oxford Nanopore to 720 GBp from 710 GBp and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
ONTTF Oxford Nanopore
$3.35 /

+0.03 (+0.90%)

ONTTF Oxford Nanopore
$3.35 /

+0.03 (+0.90%)

08/23/22 Barclays
Oxford Nanopore price target lowered to 420 GBp from 500 GBp at Barclays
05/31/22 Barclays
Oxford Nanopore price target lowered to 500 GBp from 700 GBp at Barclays
04/29/22 RBC Capital
Oxford Nanopore price target lowered to 400 GBp from 700 GBp at RBC Capital
03/29/22 JPMorgan
Oxford Nanopore price target lowered to 710 GBp from 790 GBp at JPMorgan
Over a quarter ago
Recommendations
Oxford Nanopore price target lowered to 420 GBp from 500 GBp at Barclays » 14:05
08/23/22
08/23
14:05
08/23/22
14:05
ONTTF

Oxford Nanopore

$3.42 /

-0.2755 (-7.45%)

Barclays analyst Hassan…

Barclays analyst Hassan Al Wakeel lowered the firm's price target on Oxford Nanopore to 420 GBp from 500 GBp and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
ONTTF Oxford Nanopore
$3.42 /

-0.2755 (-7.45%)

ONTTF Oxford Nanopore
$3.42 /

-0.2755 (-7.45%)

05/31/22 Barclays
Oxford Nanopore price target lowered to 500 GBp from 700 GBp at Barclays
04/29/22 RBC Capital
Oxford Nanopore price target lowered to 400 GBp from 700 GBp at RBC Capital
03/29/22 JPMorgan
Oxford Nanopore price target lowered to 710 GBp from 790 GBp at JPMorgan
03/17/22 Citi
Oxford Nanopore upgraded to Buy from Neutral at Citi
Recommendations
Oxford Nanopore price target lowered to 500 GBp from 700 GBp at Barclays » 15:35
05/31/22
05/31
15:35
05/31/22
15:35
ONTTF

Oxford Nanopore

$4.15 /

+0.045 (+1.10%)

Barclays lowered the…

Barclays lowered the firm's price target on Oxford Nanopore to 500 GBp from 700 GBp and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
ONTTF Oxford Nanopore
$4.15 /

+0.045 (+1.10%)

ONTTF Oxford Nanopore
$4.15 /

+0.045 (+1.10%)

04/29/22 RBC Capital
Oxford Nanopore price target lowered to 400 GBp from 700 GBp at RBC Capital
03/29/22 JPMorgan
Oxford Nanopore price target lowered to 710 GBp from 790 GBp at JPMorgan
03/17/22 Citi
Oxford Nanopore upgraded to Buy from Neutral at Citi
03/02/22 Piper Sandler
Oxford Nanopore initiated with an Overweight at Piper Sandler
Recommendations
Oxford Nanopore price target lowered to 400 GBp from 700 GBp at RBC Capital » 14:35
04/29/22
04/29
14:35
04/29/22
14:35
ONTTF

Oxford Nanopore

$4.15 /

+0.05 (+1.22%)

RBC Capital analyst…

RBC Capital analyst Charles Weston lowered the firm's price target on Oxford Nanopore to 400 GBp from 700 GBp and keeps an Outperform rating on the shares.

ShowHide Related Items >><<
ONTTF Oxford Nanopore
$4.15 /

+0.05 (+1.22%)

ONTTF Oxford Nanopore
$4.15 /

+0.05 (+1.22%)

03/29/22 JPMorgan
Oxford Nanopore price target lowered to 710 GBp from 790 GBp at JPMorgan
03/17/22 Citi
Oxford Nanopore upgraded to Buy from Neutral at Citi
03/02/22 Piper Sandler
Oxford Nanopore initiated with an Overweight at Piper Sandler
01/04/22 JPMorgan
Oxford Nanopore price target raised to 790 GBp from 725 GBp at JPMorgan
Hot Stocks
Oxford Nanopore says Genomics England expands nanopore use in cancer » 09:20
04/04/22
04/04
09:20
04/04/22
09:20
ONTTF

Oxford Nanopore

$5.16 /

-0.3155 (-5.76%)

Oxford Nanopore has…

Oxford Nanopore has announced the next steps in its collaboration with Genomics England, which is using nanopore technology in an ongoing proof-of-concept project to evaluate the clinical and research applications of comprehensive genomic analysis of cancer tumours. Following successful completion of an initial phase of the project, where Genomics England generated and analysed nanopore sequence data on several hundred tumour samples from across its cancer programme, the next phase will focus in more depth and at larger scale on haemato-oncology, sarcoma and brain tumours. Genomics England researchers will use Oxford Nanopore technology to investigate methylation, SV calling, copy number variant analysis and single nucleotide polymorphism detection in the samples. The work is expected to be performed on PromethION 48 devices, the highest-output nanopore sequencers, capable of running up to 48 flow cells at once and performing all these types of variant analyses simultaneously. Genomics England has one of the world's largest collections of short-read sequence data from matched patient germline and tumour samples, and one key aim of this project is to resolve structural variants and other features and regions of the genome that can be missed by short-read sequencing. The team are also able to simultaneously analyse base modifications in the same data set, potentially enabling faster turnaround times critical in clinical care.

ShowHide Related Items >><<
ONTTF Oxford Nanopore
$5.16 /

-0.3155 (-5.76%)

ONTTF Oxford Nanopore
$5.16 /

-0.3155 (-5.76%)

03/29/22 JPMorgan
Oxford Nanopore price target lowered to 710 GBp from 790 GBp at JPMorgan
03/17/22 Citi
Oxford Nanopore upgraded to Buy from Neutral at Citi
03/02/22 Piper Sandler
Oxford Nanopore initiated with an Overweight at Piper Sandler
01/04/22 JPMorgan
Oxford Nanopore price target raised to 790 GBp from 725 GBp at JPMorgan
Hot Stocks
Oxford Nanopore provides updates in sequencing chemistry » 09:28
03/30/22
03/30
09:28
03/30/22
09:28
ONTTF

Oxford Nanopore

$5.48 /

+ (+0.00%)

Oxford Nanopore…

Oxford Nanopore Technologies plc: Summary: Latest chemistry enables 99.3% raw read accuracy at high data yields; new Kit 14 and flow cells containing R10.4.1 pore will be provided as an upgrade to the current Kit 12 chemistry and R10.4 pore, and eventually replace the R9 chemistry versions; Remora, a tool that offers real time methylation analysis is shown to outperform bisulfite sequencing; Short Fragment Mode is now allowing users to choose fragments from 20 bases long to millions; methylation analysis of shorter fragments enabled; new basecaller, Dorado, introduced to support high performance and broader hardware compatibility. Updates in sequencing chemistry to enhance performance: Nanopore sequencing enables the analysis of native DNA/RNA and sequencing of any length fragment from short to ultra-long, enabling the elucidation of all types of genetic and epigenetic variants. Oxford Nanopore continuously drives further performance enhancements by iterating its technology to deliver improving raw read accuracy. Since 2021, users have been able to achieve greater than99% raw read accuracy using the most recent Kit 12 chemistry and R10.4 pore, and today Clive Brown introduces chemistry updates that bring improved data output alongside delivery of greater than99% raw read accuracy. The Oxford Nanopore team has successfully modified the pore, motor and run conditions to increase speed that DNA/RNA is passed through the nanopore, therefore increasing the data yield while retaining high-accuracy data. This latest update will be included in a new kit, to be used alongside a new pore which has been shown to achieve 99.3% raw read accuracy, whilst maintaining speeds of 420 bases per second - a similar speed to the current high-yield R9.4.1 flow cells. Further to this, to provide users with everything they need in one kit, Kit 14 will allow users to tune their accuracy and output needs by modifying the run conditions, which will be programmable in the software. Early work has shown that the highest raw accuracy can be achieved when run at 28 degrees. At 35 degrees, it's possible to maintain greater thanQ20 raw accuracy whilst generating a higher yield. The Duplex method, where template and complement strands are paired informatically, is also improved with the new chemistry, with users now able to achieve greater thanQ30 modal accuracy following kit updates. As the R10 pores and compatible chemistries continue to improve, Oxford Nanopore plans to discontinue the R9 pore. This is expected to be towards the end of 2023, ensuring parity of kit performance across all technology applications and allowing for a suitable transition period, through which users will be supported.

ShowHide Related Items >><<
ONTTF Oxford Nanopore
$5.48 /

+ (+0.00%)

03/29/22 JPMorgan
Oxford Nanopore price target lowered to 710 GBp from 790 GBp at JPMorgan
03/17/22 Citi
Oxford Nanopore upgraded to Buy from Neutral at Citi
03/02/22 Piper Sandler
Oxford Nanopore initiated with an Overweight at Piper Sandler
01/04/22 JPMorgan
Oxford Nanopore price target raised to 790 GBp from 725 GBp at JPMorgan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.